Global Antifungal infection Therapeutics market cagr 6.8%

Antifungal infection Therapeutics Market

Antifungal infection Therapeutics Market Scope:

Industry Analysis, Market Size, Growth, Trends Till

2031

Request Sample Report

Antifungal infection Therapeutics Market Size and Growth

The global Antifungal infection Therapeutics market is expected to experience significant growth due to the rising prevalence of fungal infections. Market size is projected to reach $14.3 billion by 2025, driven by increasing awareness of fungal infections and advancements in drug development. Key players include Pfizer, Merck & Co., and Novartis. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Scynexis

◍ Sanofi-Aventis

◍ Pfizer

◍ Novartis

◍ Merck & Co

◍ Kramer Laboratories

◍ Johnson & Johnson

◍ ID Sigma-Aldrich Corporation

◍ Glenmark Pharmaceuticals

◍ Glaxosmithkline

◍ Enzon Pharmaceuticals

◍ Bayer Healthcare

◍ Astellas Pharma

◍ Asperqillus

◍ Alternaria

◍ Abbott Laboratories

The antifungal infection therapeutics market is highly competitive with key players such as Scynexis, SanofiAventis, Pfizer, Novartis, Merck & Co, Johnson & Johnson, Glenmark Pharmaceuticals, and GlaxoSmithKline. These companies develop and market antifungal treatments to combat various fungal infections. Sales revenue figures: Pfizer $41.9B, Novartis $49.6B, Merck & Co $42.3B.

Request Sample Report

Market Segmentation

By Application

Powders

Pastes

Ointments

Drugs

Other Applications

Request Sample Report

By Product

Polyenes

Echinocandins

Azoles

Allylamines

Other Drug types

Market Growth

Request Sample Report

$ X Billion USD